SI
CELG

Sofinnova Investments’s Celgene Corp CELG Stock Holding History

Sofinnova Investments’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-184,399
Closed -$14.6M – 73
2018
Q2 		$14.6M Buy
+184,399
New +$15.3M 1.66% 14

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sofinnova Investments's CELG Position: Q3 2018 in Review

Sofinnova Investments sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 184,399 shares — an estimated $14.6M sold.

Sofinnova Investments first reported a position in CELG in Q2 2018 and held it in 1 quarter. The position peaked at $14.6M in Q2 2018. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Sofinnova Investments reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Sofinnova Investments sold 184,399 Celgene Corp shares in Q3 2018, an estimated $14.6M.
  • Sofinnova Investments first reported a position in Celgene Corp in Q2 2018 and held it in 1 quarter.
  • Sofinnova Investments's Celgene Corp position peaked at $14.6M in Q2 2018.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Sofinnova Investments's 13F filing for Q3 2018, filed 15 Nov 2018.